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ABSTRACT
We examined the functional heterogeneity of
eosinophils from an adult T-cell leukemia (ATL) patient
with eosinophilia. A 63-year-old man was admitted to
our hospital because of lymphadenopathy. The leuko-
cyte count was 10 400 /mm3, with 36.0% eosinophils
and 3.0% abnormal lymphocytes. The diagnosis of
ATL was based on the presence in serum of anti-
human T-cell lymphotrophic virus-1 antibody and on
histologic demonstration of ATL cells. The mononuclear
cells spontaneously produced eosinophil-related
cytokines (granulocyte–macrophage colony stimulat-
ing factor, 5600 pg/mL; interleukin (IL)-5, 375 pg/mL).
Peripheral eosinophils were fractionated into normod-
ense eosinophils (NE) and hypodense eosinophils (HE)
by a Percoll density gradient method, and these cells
were compared in terms of several heterogeneous
functions. The NE were more chemotactically attracted
to IL-5 than the HE. More apoptotic cells appeared
among the NE than among the HE and this difference
was correlated with the positive rate of Fas antigen on
eosinophils. Survival of the HE was longer than that of
the NE. Survival of the HE was prolonged by IL-5 stim-
ulation, but survival of the NE was not. These data
suggest that functionally heterogeneous eosinophils
were present in this ATL patient with eosinophilia and
that IL-5 enhanced this heterogeneity. The response of
eosinophils to IL-5 may have contributed to the patho-
genesis of eosinophilia in this patient.
Key words: adult T-cell leukemia, eosinophil hetero-
geneity, interleukin-5.
INTRODUCTION
T cells infected with human T-cell lymphotrophic virus
(HTLV)-1 are known to constitutively produce a number of
cytokines, such as interleukin (IL)-2, IL-3, and granulo-
cyte–macrophage colony-stimulating factor (GM-CSF).1,2
Patients with adult T-cell leukemia (ATL) display several
peculiar clinical features, including skin rash, hyper-
calcemia and an increase in absolute neutrophil count.
Adult T-cell leukemia is only rarely accompanied by
eosinophilia.3 The mechanism of eosinophilia in ATL
patients has been examined by several investigators who
have reported that GM-CSF and several eosinophil
chemotactic factors (ECF) are produced by ATL cells.1,4
Several reports of patients with eosinophilia have demon-
strated IL-5 to be an important factor in the pathogenesis
of the disease.5,6 Reports, however, about the functional
relationship between IL-5 and eosinophilia in ATL are
lacking. We evaluated the functional heterogeneity of
density fractionated eosinophils and its correlation with
cytokines, especially IL-5, produced by mononuclear
cells from an ATL patient with eosinophilia. This is the first
report of the functional characterization of IL-5 and
eosinophilia in ATL, to our knowledge.
Clinical summary
A 63-year-old man was admitted to our hospital because
of lymphadenopathy. Systemic peripheral lymph node
Allergology International (2000) 49: 167–171
Case Report
Spontaneous production of interleukin-5 and its 
heterogeneous effect on eosinophils in an adult T-cell
leukemia patient
Naoki Saita, Eisuke Goto, Hirotsugu Kohrogi, Tohru Yamanaka, Keisuke
Setoguchi, Yumi Nonaka and Masayuki Ando
First Department of Internal Medicine, Kumamoto University, School of Medicine, Kumamoto, Japan
Correspondence: Dr Naoki Saita, First Department of Internal
Medicine, Kumamoto University, School of Medicine, 1-1-1
Honjo, Kumamoto 860-0811, Japan. 
Email: saita@kumamoto-u.ac.jp
Received 1 July 1999. Accepted for publication 21 February
1999.
swelling was present. The leukocyte count was
10 400/mm3, with 36.0% eosinophils and 3.0% abnor-
mal lymphocytes. He was diagnosed with ATL based on
high titers of serum anti-HTLV-1 antibody (211) and anti-
IL-2 receptor antibody (29 510 U/mL). Histologic
examination of a cervical lymph node showed invasion of
diffuse pleomorphic small lymphoma cells (ATL cells) and
infiltration of eosinophils.
METHODS
Preparation of eosinophils and mononuclear
leukocyte cells
The patient’s peripheral eosinophils were fractionated into
normodense eosinophils (NE) and hypodense eosinophils
(HE) by a Percoll density gradient method and with the
depletion of neutrophils by an immunomagnetic method.7
The eosinophil-rich fraction was more than 98% pure and
the viability was greater than 99%, as shown by Giemsa
staining and trypan blue dye exclusion test.
The patient’s mononuclear leukocyte cells (MNL) were
separated by Ficoll-Paque centrifugation at 400 g for
40 min and washed three times with phosphate-buffered
saline (PBS, pH 7.4). The cells were suspended (1 · 106)
in RPMI-1640 medium supplemented with 10% fetal calf
serum, 100 U/mL penicillin and 100 mg/mL streptomycin
and cultured at 37°C in a 5% CO2-containing atmos-
phere for 72 h. Cell-free culture supernatant was assessed
for eosinophil-related cytokines by enzyme-linked
immunosorbent assay (ELISA).
Comparison of function of density fractionated
eosinophils
We evaluated the functional heterogeneity of the fraction-
ated eosinophils based on chemotactic activity, cell
surface markers, apoptosis and survival rate. All experi-
ments were done twice or three times with freshly isolated
peripheral blood. Chemotaxis was assessed as previously
described.4 Briefly, a 48-well chemotaxis chamber with 
a polyvinylpyrrolidone-free 5 mm nucleopore filter was
used and the chamber was incubated at 37°C for 90 min.
After staining with Diff-Quick (International Reagents Co.,
Kobe, Japan), the cells that migrated through the filter
were counted on five high-power fields (HPF, 40 · 10).
We assessed surface antigen expression on the
eosinophils. The eosinophils were incubated for 30 min
with monoclonal antibodies directed against Fas
(Immunotech, Marseille, France) and very late activation
antigen (VLA)-4 (Biodesign, Kennebunk, ME, USA). Cells
were analyzed on a FACScan (Becton Dickinson, Moun-
tain View, CA, USA).
The rate of apoptosis of the eosinophils after a 24 h
culture at 37°C in a 5% CO2-containing atmosphere was
detected with an apoptosis detection kit (Annexin V FITC
Kit, Immunotech).8 The specific binding of annexin V-FITC
was achieved by the incubation of eosinophils (1 · 105)
for 10 min at 4°C in 490 mL of binding buffer (10 mmol/
L N-2-hydroxyethylpiperazine-N¢ -2-ethanesulfonic acid
(HEPES), 140 mmol/L NaCl, 2.5 mmol/L CaCl2 pH 7.4)
containing a saturating concentration of annexin V-
fluorescein isothiocyanate (FITC). After incubation, the
eosinophils were pelleted at 400 g for 3 min at 4°C . The
cells were analyzed on a FACScan within 1 h.
The viability of the eosinophils was evaluated by the
trypan blue exclusion method after 1, 3, 5, 7 and 10 days
and the effect of IL-5 on eosinophil survival was also
assessed.
RESULTS
Peripheral MNL from our ATL patient constitutively pro-
duced IL-5 (ELISA 375 pg/mL) and GM-CSF (ELISA
5600 pg/mL). Interleukin-3 was not detected. The density
gradient revealed a NE:HE ratio of approximately 1:3.
The chemotactic responses of NE and HE to GM-CSF, 
IL-3, and IL-5 were evaluated. The NE were more chemo-
tactically attracted to IL-5 and GM-CSF than were the HE
(Fig. 1). Although the responses of both types of eosino-
phils to IL-3 were low, the activity of the HE was slightly
stronger than that of the NE.
We then analyzed the eosinophils for surface antigens.
The expressions of Fas and VLA-4 on the two types of
eosinophils differed. The positive rate of Fas antigen of
the NE was higher than that of the HE (51% vs 29%;
Fig. 2a,c); the positive rate of VLA-4 of the NE was lower
than that of the HE (57% vs 87%; Fig. 2b,d). The differing
Fas expression was correlated with the rate of apoptosis.
The NE were more apoptotic than the HE after the 24 h
incubation (11% vs 3%; Fig. 3). Because the rate of
viable cells was also different (NE 29% vs HE 53%), we
examined the time kinetics of the viability of the density
fractionated eosinophils. Most of the NE were dead after
a 3 day incubation and most of the HE were dead after 
5 days. Survival of the HE was significantly enhanced by
IL-5 stimulation (10 ng/mL) for 5 days and 7 days, but
survival of the NE was not (Fig. 4).
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DISCUSSION
In this ATL case, the density fractionated eosinophils 
displayed several different functions and IL-5 enhanced this
heterogeneity. The NE were more chemotactically attracted
to IL-5 than were the HE and were more likely to undergo
apoptosis. The HE survived longer than the NE and IL-5
enhanced the survival of only the HE. These data sug-
gested that the eosinophil response to IL-5 may have been
a part of the pathogenesis of eosinophilia in this patient.
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Fig. 1 The chemotactic responses of density-fractionated
eosinophils to phosphate-buffered saline (PBS), granulocyte–
macrophage colony stimulating factor (GM-CSF), interleukin
(IL)-3 and IL-5. ( ), normodense eosinophils; (h), hypodense
eosinophils. Data are shown as the mean number of migrated
cells/5 high-power fields (h.p.f.) from three independent exper-
iments (*P < 0.05).
Fig. 2 Comparison of the expression of surface antigens Fas
(a,c) and VLA-4 (b,d) on normodense (a,b) and hypodense (c,d)
eosinophils by fluorescence-activated cell sorting (FACScan).
One representative scan of three independent experiments is
shown.
Fig. 3 The rates of apoptotic,
viable, and necrotic normod-
ense (NE) and hypodense (HE)
eosinophils. The NE (a) and HE
(b) cells were cultured for 24 h.
The cells were harvested and
the rate of apoptosis was
assessed with an annexin-V
fluorescein isothiocyanate kit
and analyzed on a fluores-
cence-activated cell sorter
(FACScan). In each scan, the
right upper quadrant shows
necrosis, the left lower quadrant
shows viable cells and right
lower quadrant shows early
apoptosis. One representative
scan of three independent
experiments is shown.
Clinically, ATL displays several peculiar manifestations,
including skin rash and hypercalcemia; increased
eosinophil count is observed only occasionally.3 These
features have been correlated with production of a
number of cytokines from T cells infected with HTLV-1.1,2
An investigation into the mechanism of eosinophilia in an
ATL patient has demonstrated that GM-CSF is produced
by ATL cells.1 Hirashima et al. have established a T cell
line by ATL virus-induced transformation that constitu-
tively produced several ECF,4 demonstrating such
production to contribute to the pathogenesis of eosino-
philia. In our patient, peripheral mononuclear cells
constitutively produced GM-CSF. Interleukin-5 was also
detected in the culture supernatant of the patient’s MNL.
This is the first report of the functional characterization of
IL-5 and eosinophilia in ATL. Several reports of other
patients with eosinophilia have revealed IL-5 to be an
important factor in the pathogenesis of the disease.5,6 A
previous study has shown that the viability of eosinophils
can be prolonged by IL-5,9 and IL-5 did enhance survival
of the HE in our patient (Fig. 4). We suspect that IL-5 pro-
duction may contribute to eosinophilia in the peripheral
blood.
The present study is also the first to examine functional
difference in the apoptosis of density fractionated
eosinophils. The NE were more apoptotic than the HE
after the 24 h incubation. As Matsumoto et al. have pre-
viously reported,10 this difference was correlated with the
positive rate of Fas antigen. Several studies have demon-
strated that cell apoptosis decreases when activation of
inflammatory cells increases.11,12 Spry has reported that
activated eosinophils prolong half-life.13 The differences
that we observed could indicate that HE were more acti-
vated than NE in our patient. Other studies have shown
that HE are activated with increased oxygen consumption
and increased presence of Fc-IgG and complement
receptor.14,15
Another interesting point with regard to the activation
of eosinophils has been raised. Hirashima et al. have
demonstrated that chemotactic profiles of eosinophils in
response to ECF differ between several human diseases
characterized by eosinophilia (atopic bronchial asthma,
atopic dermatitis and Kimura’s disease).4 We, too, have
reported that the chemotactic response to different ECF
varies according to the clinical findings in Kimura’s
disease and eosinophilic pneumonia.16,17 In the present
case, the NE were more chemotactically attracted to IL-5
than were the HE. Interleukin-5 is known to play an
important role in the tissue infiltration of eosinophils. The
NE might migrate into tissue more easily than HE in
response to IL-5. Several studies have demonstrated 
differences in chemotactic response between HE and
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Fig. 4 Time kinetics of the
viability of density-fractionated
eosinophils and the effect of
interleukin (IL)-5. Eosinophils
from density-fractionated eosino-
phils were cultured with (s) or
without IL-5 (d) for 1, 3, 5, 7
and 10 days. (a) Normodense
eosinophils, (b) hypodense
eosinophils. Viability of the
eosinophils was assessed by 
the trypan blue exclusion
method. Data is from analysis
of three independent experi-
ments. *P < 0.05.
NE.16,18,19 Hirashima et al. have reported that HE in a
case of hypereosinophilic syndrome (HES) responded
more than NE to lymphocyte-derived eosinophil chemo-
tactic factor.18 In another report of HES, leukotriene B4
was more effective for chemotaxis on NE than on HE.19
We have previously reported chemotactic responses of
fractionated eosinophils in Kimura’s disease; that is, the
response of HE to one ECF was greater than that of NE
and the responses of NE to three other ECF were greater
than those of HE.16 Taken together, these findings
demonstrate that chemotactic responses of density frac-
tionated eosinophils vary according to chemotactic
factors. The postulation that HE are in the activated form
is not always true, especially during chemotactic
response. It may be necessary to rethink the activation of
eosinophils, at least in terms of chemotactic response.
Although the underlying reason for the functional dif-
ferences of density fractionated eosinophils is not yet
understood, we suggest that survival of the HE is pro-
longed by IL-5 and that HE maintain eosinophilia in the
peripheral blood. The function of NE may be related to
their ability to migrate into tissue with chemotactic attrac-
tion to IL-5. The heterogeneous eosinophil responses
suggest that a heterogeneous population of eosinophils
is induced from bone marrow. These heterogeneous
responses of eosinophils to IL-5 could shed light on the
pathogenesis of eosinophilia in ATL patients.
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